查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2132584

美國藥局市場規模、佔有率和趨勢分析報告：按產品、產品類型、所有權類型、國家和細分市場預測（2026-2033 年）

U.S. Pharmacy Market Size, Share & Trends Analysis Report By Product (Prescription, OTC), By Type (Hospital Pharmacy, Retail Pharmacy, ePharmacy), By Ownership, By Country, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國藥局市場概況

2025年美國藥局市場價值8,016億美元，預計將從2026年的8,781億美元成長到2033年的1.707兆美元，2026年至2033年的複合年成長率為10.0%。

這一成長歸因於慢性病患病率上升、處方藥使用率高以及該國老年人口不斷增加。

美國心臟協會 (AHA) 於 2024 年 1 月發布的報告指出，美國民眾對心血管健康的認知有顯著不足。儘管心臟病已連續 100 多年蟬聯美國頭號死因，但受訪的美國成年人中，51% 的人並未意識到心臟病是頭號死因，另有 18% 的人誤認為癌症才是頭號死因。這種認知不足尤其令人擔憂，因為心血管疾病影響 48.6% 的美國人口，而 46.7% 的成年人患有高血壓，其中 38% 的人對此毫不知情。

以下各節概述了美國藥局市場成長的關鍵促進因素，重點在於慢性病盛行率的上升以及對處方藥和長期藥物管理日益成長的需求。此外，還探討了專科藥物和高成本治療方案的日益普及、以藥房為基礎的醫療保健服務（例如疫苗接種、慢性病管理和藥物檢驗）的成長，以及數位技術、電子藥房服務、郵購服務和遠距藥事照護的日益融合。

目錄

第1章：本報告的範圍與調查方法

第2章執行摘要

第3章：美國藥局市場－產業展望

  • 市場譜系展望
  • 市場動態
  • 監管趨勢和還款前景
  • 商業環境分析工具

第4章：美國藥局市場：產品細分估算與趨勢分析

  • 產品特定趨勢分析、市佔率分析（2025 年及 2033 年）
  • 美國藥局市場規模及預測（依產品類別分類）
    • 處方
    • 非處方藥（OTC）

第5章：美國藥局市場：按類型分類的估算與趨勢分析

  • 基於類型的趨勢分析、市場佔有率分析，2025 年和 2033 年
  • 美國藥房市場規模及預測（按類型分類，2021-2033 年）
  • 美國藥房市場：按類型分類的門市數量預測，2021-2033 年（單位）
  • 美國藥局市場：處方箋量預估（按類型分類，2021-2033 年）（單位：百萬）
  • 美國藥局市場：2025年處方箋量預估（依服務區域分類，%）
  • 美國藥局市場：2025 年處方箋處方箋（以配藥數量計）預計百分比
    • 零售連鎖店
    • 超級市場內的藥房
    • 醫療保健系統/醫院藥房
    • 獨立藥房
    • 郵購藥房
    • 特藥/中央菲律賓藥房
    • 與長期照護和國防相關的藥房
    • Epharmacy
    • 其他

第6章：美國藥局市場：依所有權類型分類的估算與趨勢分析

  • 按所有權類型分類的趨勢分析、市場佔有率分析（2026 年和 2033 年）
  • 美國藥局市場規模及預測（依所有權類型分類，2021-2033 年）
    • 連鎖店
    • 獨立的
Product Code: GVR-4-68040-044-6

U.S. Pharmacy Market Summary

The U.S. pharmacy market size was valued at USD 801.6 billion in 2025 and is projected to grow from USD 878.1 billion in 2026 to USD 1707.0 billion by 2033, at a CAGR of 10.0% from 2026 to 2033. The growth is attributed to the rising prevalence of chronic diseases, the high utilization of prescription drugs, and the increasing elderly population in the country.

A report published in January 2024 by American Heart Association (AHA) highlights a significant awareness gap surrounding cardiovascular health in the U.S. Despite heart disease remaining the country's leading cause of death for more than 100 years, 51% of surveyed U.S. adults did not identify it as the leading cause of death, while 18% incorrectly identified cancer as the leading cause. This lack of awareness is particularly concerning because cardiovascular disease affects 48.6% of the U.S. population, and 46.7% of adults have high blood pressure, with 38% of those individuals unaware of their condition.

The section below outlines the key factors driving the growth of the U.S. market for pharmacy, highlighting the rising prevalence of chronic diseases and the increasing need for prescription medications and long-term medication management. It also examines the growing adoption of specialty drugs and high-cost therapies, the expansion of pharmacy-based healthcare services such as vaccinations, chronic disease management, and medication counseling, and the increasing integration of digital technologies, ePharmacies, mail-order services, and tele-pharmacy.

U.S. Pharmacy Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. pharmacy market report based on type, product, and ownership.

  • Type Outlook (Revenue, USD Billion, 2021 - 2033)
  • Retail chains (e.g., Walgreens, CVS)
    • Supermarket pharmacies
    • Health system / hospital pharmacies
    • Independent pharmacies
    • Mail-order pharmacies
    • Specialty / central fill pharmacies
    • Long-term care and defense-related pharmacies
    • ePharmacy
    • Others
  • Product Outlook (Revenue, USD Billion, 2021 - 2033)
    • Prescription
    • OTC
  • Ownership Outlook (Revenue, USD Billion, 2021 - 2033)
    • Chain
    • Independent
  • Country Outlook (Revenue, USD Billion, 2021 - 2033)
    • Southeast
    • Southwest
    • West
    • Midwest
    • Northeast

Table of Contents

Chapter 1. Report Scope & Research Methodology

  • 1.1 Market Segmentation
    • 1.1.1 Segment Definition
      • 1.1.1.1 Product
      • 1.1.1.2 Type
      • 1.1.1.3 Ownership
  • 1.2 Estimates and Forecast Timeline
  • 1.3 Research Methodology
    • 1.3.1 Information Procurement
    • 1.3.2 Purchased Database
    • 1.3.3 GVR's Internal Database
    • 1.3.4 Secondary Sources
    • 1.3.5 Primary Research
    • 1.3.6 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Three Pillars of Market Estimation
      • 1.6.1.1 Secondary Market Research
      • 1.6.1.2 Primary Market Intelligence
        • 1.6.1.2.1 In-Depth Interviews (IDIs)
        • 1.6.1.2.2 Online Survey Program
    • 1.6.2 Market Modeling & Forecasting
      • 1.6.2.1 Model 1: Volume-Price Analysis
        • 1.6.2.1.1 Step 1: Prescription volume estimation
        • 1.6.2.1.2 Channel-Wise Methodology
          • 1.6.2.1.2.1 Retail Chains (CVS, Walgreens, etc.)
          • 1.6.2.1.2.2 Supermarket Pharmacies (Kroger, Albertsons, Publix)
          • 1.6.2.1.2.3 Health System / Hospital Outpatient Pharmacies
          • 1.6.2.1.2.4 Independent Pharmacies
          • 1.6.2.1.2.5 Mail-Order Pharmacies
          • 1.6.2.1.2.6 Specialty / Central Fill Pharmacies
          • 1.6.2.1.2.7 Long-Term Care (LTC) and Defense-Related Pharmacies
          • 1.6.2.1.2.8 ePharmacies (Amazon, Capsule, Hims & Hers, etc.)
          • 1.6.2.1.2.9 Other Channels
          • 1.6.2.1.2.10 Aggregation & Triangulation
        • 1.6.2.1.3 Step 2: Determining Average Realized Price (ARP)
        • 1.6.2.1.4 Step 2: OTC Revenue
      • 1.6.2.2 Model 2: Company Market Share Analysis
        • 1.6.2.2.1 Step 1: Public Filings
        • 1.6.2.2.2 Step 2: Private & Independent Estimates
        • 1.6.2.2.3 Step 3: Market Share Allocation
      • 1.6.2.3 CAGR/Forecasting Calculations & Assumptions
        • 1.6.2.3.1 Key Forecasting Drivers and Weights
        • 1.6.2.3.2 Scenario Framework (2026 - 2033)
        • 1.6.2.3.3 Factor-Based Impact Assessment
    • 1.6.3 Estimation Process: Pharmacy Split By Catchment Area
      • 1.6.3.1 Data Sources
      • 1.6.3.2 Estimation Process
    • 1.6.4 Estimation Process: Pharmacy Split By Product Form
    • 1.6.5 Company-Level Metric's Estimation
      • 1.6.5.1 Financial Performance
        • 1.6.5.1.1 2025 Revenue & EBITDA (Pharmacy-Only)
        • 1.6.5.1.2 5-Year Forecast of Revenue & EBITDA
        • 1.6.5.1.3 Balance Sheet Health Indicators
      • 1.6.5.2 Volumes & Operations
        • 1.6.5.2.1 2025 Total Prescriptions; 5-Year Rx Forecast
        • 1.6.5.2.2 % Fulfilled via Central Fill; Volumes Split by Catchment Area
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Research Objectives
    • 1.9.1 Objective - 1
    • 1.9.2 Objective - 2
    • 1.9.3 Objective - 3

Chapter 2. Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Outlook - I
  • 2.3 Segment Outlook- II
  • 2.4 Competitive Scenario

Chapter 3. U.S. Pharmacy Market - Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related Market Outlook
      • 3.1.2.1 U.S. pharmacy benefit management market
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Technological advancements
      • 3.2.1.3 Expanding health insurance coverage
      • 3.2.1.4 Increasing demand for specialty drugs
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Product recalls and lawsuits
      • 3.2.2.2 Lack of trained staff
    • 3.2.3 Market Opportunity Analysis
    • 3.2.4 Market Challange Analysis
  • 3.3 Regulatory Scenario & Reimbursement Outlook
    • 3.3.1 Regulatory Scenario
    • 3.3.2 Reimbursement Scenario
  • 3.4 Business Environment Analysis Tools
    • 3.4.1 Porter's Five Forces Analysis
    • 3.4.2 Pestle Analysis

Chapter 4. U.S. Pharmacy Market: Product Estimates & Trend Analysis

  • 4.1 U.S. Pharmacy Market: Product Segment Dashboard
  • 4.2 Product Movement & Market Share Analysis, 2025 & 2033
  • 4.3 U.S. Pharmacy Market Size & Forecast and Forecasts, By Product (USD Billion)
    • 4.3.1 Prescription
      • 4.3.1.1 Prescription market, 2021 - 2033 (USD Billion)
    • 4.3.2 Over-the-Counter (OTC)
      • 4.3.2.1 OTC market, 2021 - 2033 (USD Billion)

Chapter 5. U.S. Pharmacy Market: Type Estimates & Trend Analysis

  • 5.1 U.S. Pharmacy Market: Type Segment Dashboard
  • 5.2 Type Movement & Market Share Analysis, 2025 & 2033
  • 5.3 U.S. Pharmacy Market Size & Forecast and Forecasts, By Type, 2021 - 2033 (USD Billion)
  • 5.4 U.S. Pharmacy Market: Estimated Number of Pharmacies, By Type, 2021 - 2033 (Unit)
  • 5.5 U.S. Pharmacy Market: Estimated Prescription Volume, By Type, 2021 - 2033 (Million)
  • 5.6 U.S. Pharmacy Market: Estimated Prescription Volume, By Catchment Area, 2025 (%)
  • 5.7 U.S. Pharmacy Market: Estimated Prescription Volume, By Filled Prescriptions (TRx), 2025 (%)
    • 5.7.1 Retail Chains
      • 5.7.1.1 Retail chains market, 2021 - 2033 (USD Billion)
    • 5.7.2 Supermarket Pharmacies
      • 5.7.2.1 Supermarket pharmacies market, 2021 - 2033 (USD Billion)
    • 5.7.3 Health System / Hospital Pharmacy
      • 5.7.3.1 Health system / Hospital pharmacy market, 2021 - 2033 (USD Billion)
    • 5.7.4 Independent Pharmacies
      • 5.7.4.1 Independent pharmacies market, 2021 - 2033 (USD Billion)
    • 5.7.5 Mail-Order Pharmacies
      • 5.7.5.1 Mail-order pharmacy market, 2021 - 2033 (USD Billion)
    • 5.7.6 Specialty / Central Fill Pharmacies
      • 5.7.6.1 Specialty / central fill pharmacies market, 2021 - 2033 (USD Billion)
    • 5.7.7 Long-Term Care And Defense-Related Pharmacies
      • 5.7.7.1 Long-term care and defense-related pharmacies market, 2021 - 2033 (USD Billion)
    • 5.7.8 Epharmacy
      • 5.7.8.1 ePharmacy market, 2021 - 2033 (USD Billion)
    • 5.7.9 Others
      • 5.7.9.1 Others market, 2021 - 2033 (USD Billion)

Chapter 6. U.S. Pharmacy Market: Ownership Estimates & Trend Analysis

  • 6.1 U.S. Pharmacy Market: Ownership Segment Dashboard
  • 6.2 Ownership Movement & Market Share Analysis, 2026 & 2033
  • 6.3 U.S. Pharmacy Market Size & Forecast and Forecasts, By Ownership, 2021 - 2033 (USD Billion)
    • 6.3.1 Chains
      • 6.3.1.1 Chains market, 2021 - 2033 (USD Billion)
    • 6.3.2 Independent
      • 6.3.2.1 Independent market, 2021 - 2033 (USD Billion)

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Specialty drug expenditures
  • Table 4 U.S. pharmacy market revenue estimates and forecast, by product, 2021 - 2033 (USD Billion)
  • Table 5 U.S. pharmacy market revenue estimates and forecast, by type, 2021 - 2033 (USD Billion)
  • Table 6 U.S. pharmacy market: Estimated number of pharmacies, by type, 2021 - 2033 (Unit)
  • Table 7 U.S. pharmacy market: Estimated prescription volume, by type, 2021 - 2033 (Million)
  • Table 8 U.S. pharmacy market revenue estimates and forecast, by ownership, 2021 - 2033 (USD Billion)
  • Table 9 U.S. pharmacy market: Estimated prescription volume, by catchment area, 2025 (%)
  • Table 10 U.S. pharmacy market: Estimated prescription volume, by filled prescriptions (TRx), 2025 (%)

List of Figures

  • Fig.1 U.S. pharmacy market segmentation
  • Fig.2 Market research process
  • Fig.3 Information procurement
  • Fig.4 Primary research pattern
  • Fig.5 Market research approaches
  • Fig.6 Value-chain-based sizing & forecasting
  • Fig.7 Market formulation & validation
  • Fig.8 Market snapshot
  • Fig.9 Segment outlook-I
  • Fig.10 Segment outlook-II
  • Fig.11 Competitive scenario
  • Fig.12 U.S. pharmacy market: Parent market outlook
  • Fig.13 U.S. pharmacy market: Ancillary/related market outlook
  • Fig.14 U.S. pharmacy market dynamics
  • Fig.15 Market driver relevance analysis (Current & future impact)
  • Fig.16 Estimated New Cancer Cases, 2025
  • Fig.17 Estimated U.S. prevalence of stroke, 2021 - 2033
  • Fig.18 Estimated U.S. prevalence of prostate cancer, 2021 - 2033
  • Fig.19 Estimated U.S. prevalence of kidney cancer, 2021 - 2033
  • Fig.20 Market restraint relevance analysis (Current & future impact)
  • Fig.21 Number of pharmacy degrees conferred 2021 - 2024 by gender
  • Fig.22 U.S. pharmacy market: Porter's five forces analysis
  • Fig.23 U.S. pharmacy market: PESTLE analysis
  • Fig.24 U.S. pharmacy market: Product segment dashboard
  • Fig.25 U.S. pharmacy market: Product market share analysis, 2025 & 2033
  • Fig.26 Prescription market, 2021 - 2033 (USD Billion)
  • Fig.27 OTC market, 2021 - 2033 (USD Billion)
  • Fig.28 U.S. pharmacy market: Type segment dashboard
  • Fig.29 U.S. pharmacy market: Type market share analysis, 2025 & 2033
  • Fig.30 Retail pharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
  • Fig.31 Supermarket pharmacies market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
  • Fig.32 Health system / hospital pharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
  • Fig.33 Independent pharmacies market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
  • Fig.34 Mail-order pharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
  • Fig.35 Specialty / central fill pharmacies market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
  • Fig.36 Long-term care and defense-related pharmacies market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
  • Fig.37 ePharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
  • Fig.38 Others market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
  • Fig.39 U.S. pharmacy market: Ownership segment dashboard
  • Fig.40 U.S. pharmacy market: Ownership market share analysis, 2025 & 2033
  • Fig.41 Chain pharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
  • Fig.42 Independent pharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
  • Fig.43 Key company categorization
  • Fig.44 Estimated company market share analysis, 2025